 Brokerages forecast that Kindred Biosciences Inc NASDAQ:KIN will report sales of 1.75 million for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Kindred Biosciences earnings, with the highest sales estimate coming in at 1.80 million and the lowest estimate coming in at 1.70 million. Kindred Biosciences reported sales of ... 